These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6177857)

  • 1. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
    Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
    J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin (pancreozymin). 5. Hormonally active desamino derivative of Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2.
    Bodanszky M; Martinez J; Walker M; Gardner JD; Mutt V
    J Med Chem; 1980 Jan; 23(1):82-5. PubMed ID: 6153722
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and biological activities of pseudopeptide analogues of the C-terminal heptapeptide of cholecystokinin. On the importance of the peptide bonds.
    Rodriguez M; Lignon MF; Galas MC; Fulcrand P; Mendre C; Aumelas A; Laur J; Martinez J
    J Med Chem; 1987 Aug; 30(8):1366-73. PubMed ID: 2441054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin (pancreozymin). Synthesis and properties of the N alpha-acetyl-derivative of cholecystokinin 27-33.
    Bodanszky M; Tolle JC; Gardner JD; Walker MD; Mutt V
    Int J Pept Protein Res; 1980 Nov; 16(5):402-11. PubMed ID: 6163740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of cholecystokinin analogs in which the Asp-Phe-NH2 moiety has been replaced by a 3-amino-7-phenylheptanoic acid or a 3-amino-6-(phenyloxy)hexanoic acid.
    Amblard M; Rodriguez M; Lignon MF; Galas MC; Bernad N; Artis-Noël AM; Hauad L; Laur J; Califano JC; Aumelas A
    J Med Chem; 1993 Oct; 36(20):3021-8. PubMed ID: 7692048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
    Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
    J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective modification of the ability of cholecystokinin to cause residual stimulation of pancreatic enzyme secretion.
    Villanueva ML; Martinez J; Bodanszky M; Collins SM; Jensen RT; Gardner JD
    Am J Physiol; 1982 Sep; 243(3):G214-7. PubMed ID: 6180646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.
    Charpentier B; Durieux C; Menant I; Roques BP
    J Med Chem; 1987 Jun; 30(6):962-8. PubMed ID: 2438407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
    Taniguchi H; Nagasaki M; Tamaki H
    Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
    Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
    J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boc-Trp-Orn(Z)-Asp-NH2 and derivatives: a new family of CCK antagonists.
    Gonzalez-Muniz R; Bergeron F; Marseigne I; Durieux C; Roques BP
    J Med Chem; 1990 Dec; 33(12):3199-204. PubMed ID: 1701834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between phospholipid breakdown, intracellular calcium mobilization and enzyme secretion in rat pancreatic acini treated with Boc-[Nle28, Nle31]-CCK-7 and JMV180, two cholecystokinin analogues.
    Lignon MF; Galas MC; Rodriguez M; Martinez J
    Cell Signal; 1990; 2(4):339-46. PubMed ID: 1701321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N alpha-carboxyacyl analogues of CCK with a substituted Gly: interaction with pancreatic and gallbladder CCK receptors.
    von Schrenck T; Müller K; Schulze C; Mirau S; Raedler A; Greten H
    Peptides; 1993; 14(6):1309-15. PubMed ID: 7510882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholecystokinin (pancreozymin). 3. Synthesis and properties of an analogue of the C-terminal heptapeptide with serine sulfate replacing tyrosine sulfate.
    Bodanszky M; Natarajan S; Hahne W; Gardner JD
    J Med Chem; 1977 Aug; 20(8):1047-50. PubMed ID: 894673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33.
    Solomon TE; Yamada T; Elashoff J; Wood J; Beglinger C
    Am J Physiol; 1984 Jul; 247(1 Pt 1):G105-11. PubMed ID: 6204542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro bioassays for cholecystokinin.
    Sjödin L; Nederman T; Olsson PA; Viitanen E
    J Pharm Pharmacol; 1989 Jun; 41(6):402-6. PubMed ID: 2476543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin peptides stimulate pancreatic secretion by multiple signal transduction pathways.
    Yoshida H; Tsunoda Y; Owyang C
    Am J Physiol; 1997 Sep; 273(3 Pt 1):G735-47. PubMed ID: 9316479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Z-CCK-27-32-NH2, Z-Tyr(SO-3)-Met-Gly-Trp-Met-Asp-NH2, a cholecystokinin receptor antagonist and an inhibitor of gastrin-induced acid secretion.
    Briet C; Aumelas A; Martinez J
    Int J Pept Protein Res; 1985 Sep; 26(3):294-8. PubMed ID: 2997059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.